REBECCA BELL: Open Payments
NPI 1902316961 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 9 payments from 8 companies in 2025. Trend: 2023 $51 · 2024 $57 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Eisai Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $23 |
Products named: QUTENZA, AUSTEDO XR, QULIPTA, AMYVID, KESIMPTA, Leqembi, INGREZZA, TYSABRI.
Industry payments across OH — which companies pay providers there.
